Homepage - RAPT Therapeutics
THE SCIENCE TO OVERCOME INFLAMMATORY AND IMMUNOLOGIC DISEASES Relentlessly focused on advancing treatments for patients with inflammatory and immunologic …
About Us - RAPT Therapeutics
RAPT Therapeutics is a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients living with …
Pipeline - RAPT Therapeutics
RAPT Therapeutics is focused on the development of therapies for patients with significant unmet needs in inflammatory and immunologic diseases. Utilizing our deep and proprietary expertise …
Science - RAPT Therapeutics
Our proprietary drug discovery and development engine has identified several immune drivers that have the ability to be “tuned down” to suppress an overactive immune response in …
RAPT Therapeutics Initiates prestIgE Phase 2b Clinical Trial of ...
Oct 27, 2025 · RAPT is a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients living with …
Press Releases - RAPT Therapeutics
RAPT Therapeutics Initiates prestIgE Phase 2b Clinical Trial of Ozureprubart (RPT904) in Patients with Food Allergies October 21 | 2025
RAPT Therapeutics and Shanghai Jemincare Pharmaceutical …
Dec 23, 2024 · RAPT Therapeutics is a clinical-stage, immunology-based therapeutics company focused on discovering, developing and commercializing therapies for patients with significant …
RAPT Therapeutics Reports Third Quarter 2025 Financial Results …
Sep 30, 2025 · RAPT is a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients living with …
Careers - RAPT Therapeutics
RAPT Therapeutics is a biotechnology company with an unrelenting determination and passionate drive to employ its expertise in immunology, drug discovery and computational sciences to …
RAPT Therapeutics Deepens Expertise in Allergic Diseases with ...
Apr 15, 2025 · RAPT Therapeutics is a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients …